Company Search:
Advanced Search
Sponsored Links
Genedrive PLC Company Snapshot
Genedrive PLC operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Genedrive PLC with three other companies in this sector in the United Kingdom: Physiomics PLC (2019 sales of £718,965.00 [US$922,935.37 ] of which 100% was Outsourced Systems and Computational Bio), Fusion Antibodies PLC (£2.18 million [US$2.80 million] ), and Avacta Group Plc (£4.12 million [US$5.29 million] ).

Sales Analysis. Genedrive PLC reported sales of £2.36 million (US$3.03 million) for the fiscal year ending June of 2019. This represents an increase of 21.9% versus 2018, when the company's sales were £1.94 million. Despite this increase, sales are still well below the level achieved in 2017, when Genedrive PLC reported sales of £5.79 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Genedrive PLC
  Stock Performance Chart for Genedrive PLC
  Stock Data: Recent Stock Performance:
  Current Price (11/8/2019): 18.50p
(Figures in Pounds Sterling)
1 Week 0.0%   13 Weeks 5.7%  
4 Weeks 5.7%   52 Weeks -19.6%  
Genedrive PLC Key Data:
  Ticker: GDR Country: United Kingdom
  Exchanges: LON Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 2,362,000
(Year Ending Jan 2020).
Employees: 44
  Currency: Pounds Sterling Market Cap: 6,290,094
  Fiscal Yr Ends: June Shares Outstanding: 34,000,506
  Share Type: Ordinary Closely Held Shares: 15,500,048
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.